Search

everythinglearnresearchcommunity

for

Search:↓

Metformin helps induce ovulation in obese women with PCOS, but weight loss is still the main treatment.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Myo-inositol with magnesium effectively reduces acne and hirsutism in PCOS patients without side effects.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Polycystic Ovary Syndrome (PCOS) is not very common among Iranian women, but it's important to prevent it because of the risk of heart disease and infertility.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Severe menstrual issues in PCOS women signal higher risk for heart and metabolic problems.

Ethnic Indian women with PCOS often have early symptoms, delayed diagnosis, and need better information and support for treatment and lifestyle management.

Ayurvedic treatment, including Matra basti, may help improve PCOS symptoms.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Almost 40% of Greek women with acne show signs of androgen-related disorders, with adult women more likely affected.

Women with PCOS have more severe liver disease.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

Women with PCOS have a higher risk of heart disease.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Medications for PCOS don't seem to raise heart disease risk.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Indole-based compounds improved ovarian health in rats with PCOS, with L-Tryptophan and Tryptophol being most effective.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

PCOS involves hormonal and metabolic issues, increasing risks for diabetes and heart disease, and requires lifestyle changes and medication for management.